D3-GHR Polymorphism and Turner Syndrome

首次发布于 2007 年 3 月 5 日

A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly

计划入组 34 人 · 首次发布于 2020 年 8 月 21 日

Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

计划入组 43 人 · 首次发布于 2018 年 6 月 7 日

Cimdelirsen

GHR 106-CAR-T(Protheragen)

GHRP-1

GH Research

Ireland

GROUPE HOSPITALIER DE LA REGION DE MULHOUSE ET SUD ALSACE

France

ASSOCIATION DES AUMONERIES DU GROUPE HOSPITALIER DE LA REGION DE MULHOUSE ET SUD-ALSACE

France

Marea Therapeutics Presents Phase 1 Data for MAR002, a First-in-Class GHR Antibody, Showing Up to 64% IGF-1 Suppression in Acromegaly at ENDO 2026

Growth Hormone Receptor Emerges as Promising Target for Therapy-Resistant Lung Cancer

Marea Therapeutics' MAR001 Shows Promise in Phase 2a Trial for Cardiovascular Disease; MAR002 for Acromegaly Advances